Preventive Health

Is Prevnar 21 Better Than Prevnar 20? Only 10 Strains Match

The shot people call Prevnar 21 is Capvaxive, and it shares just 10 strains with Prevnar 20. For most adults 50 and older, one shot of either is enough.

Woman in her 60s with a rolled-up coral sleeve pressing a bandage on her arm after a pneumonia shot

There’s no vaccine called Prevnar 21, and if that’s the name you heard, it’s an honest mix-up: it sounds like the next model after Prevnar 20, the way phones get a new number every year. The 21-strain shot is actually Capvaxive, a separate vaccine made by Merck, while Pfizer makes Prevnar 20. Both protect against pneumococcal bacteria, a common cause of pneumonia, and the number in each name counts how many types of those bacteria the vaccine covers. If you were just offered one of them, you’re probably wondering whether the bigger number means more protection.

Quick answer: The shot people call Prevnar 21 is Capvaxive, made by Merck, and it shares only 10 of its strains with Pfizer’s Prevnar 20. Its strains match more of the serious infections adults get today, but no study has shown it prevents more illness. The CDC lists both for adults 50 and older, and one shot of either completes the series.

In this article
  1. What do the numbers in these vaccine names mean?
  2. Which strains does each vaccine cover that the other doesn’t?
  3. Does Capvaxive protect better than Prevnar 20?
  4. Which pneumonia shot does the CDC recommend at 50 and older?

What do the numbers in these vaccine names mean?

Pneumococcal bacteria come in many types, which doctors call serotypes, and each one wears its own sugar coating. Both vaccines work the same basic way, by hanging up a set of wanted posters for your immune system. Each poster shows the sugar coat of one strain, attached to a protein so the body pays closer attention. If that strain shows up later, your immune system already knows the face and can make antibodies faster.

The number on the box tells you how many posters a vaccine puts up, but not which faces are on them. Merck built Capvaxive around a different set than Pfizer’s. A poster only helps, of course, if the face on it belongs to the strain that’s actually causing trouble. Even with a match, the shot gives your immune system a head start, though people can still get pneumococcal disease afterward.

Which strains does each vaccine cover that the other doesn’t?

Only 10 strains show up in both vaccines, which surprises a lot of people. Capvaxive leaves out half of Pfizer’s posters and swaps in new faces, most of them found in no other licensed pneumococcal vaccine.

What’s knownPrevnar 20 (Pfizer)Capvaxive (Merck)
Strains covered2021
Serious infections caused by its strains, adults 50-64About 56%About 83%
Same measure, adults 65 and olderAbout 54%About 84%
Strains only this one covers (lab names)1, 4, 5, 6B, 9V, 14, 15B, 18C, 19F, 23F9N, 15A, 15C, 16F, 17F, 20A, 23A, 23B, 24F, 31, 35B

How much does that swap matter? The CDC tracks serious infections, the kind where the bacteria reach the blood or the lining of the brain. In adults 50 to 64, Capvaxive’s strains caused about 8 in 10 of them, a much bigger share than Pfizer’s strains did. That measures how well each set of posters matches the bacteria going around. It doesn’t show that the shot prevents that many infections, even though it’s often quoted as if it did.

The one gap that can tip things the other way is serotype 4, which Pfizer’s shot includes and Capvaxive doesn’t. In places where that strain causes a large share of the illness, the CDC expects Prevnar 20, or the two-shot route described below, to cover more of what’s circulating. In most places, though, it hasn’t turned up often. That’s something the pharmacist or doctor giving the shot can weigh for you.

Does Capvaxive protect better than Prevnar 20?

It might, but nobody has shown it yet, which is frustrating when you’re the one rolling up a sleeve. Neither vaccine was approved based on a trial that counted who actually got sick. Instead, the FDA looked at antibody levels: how strongly people’s immune systems responded compared with a vaccine already in use. For some of the newer strains, the FDA gave early approval for preventing pneumonia, based on those antibody results, and the companies still owe a follow-up study to confirm it. The CDC’s vaccine advisers found no study yet that measures Capvaxive against real-world illness.

The one direct comparison, paid for by Merck, randomly assigned adults 50 and older who’d never had a pneumococcal vaccine to get one shot or the other. Capvaxive matched Pfizer’s shot on the strains they share and beat it on almost all of its extra ones. That second result isn’t much of a surprise, since Prevnar 20 doesn’t contain those strains in the first place. How long protection lasts with either shot, and whether anyone will need another one later, isn’t known yet.

Side effects look alike on both labels: a sore arm, tiredness and headache that usually fade within a day or two. Both labels also rule the shot out for anyone who’s had a severe allergic reaction, such as anaphylaxis, to an earlier dose or any of its ingredients. The same goes for a severe reaction to diphtheria toxoid, which some other vaccines contain. If your immune system is weakened, by illness or by medicine, either vaccine may not work quite as well for you, so let whoever gives the shot know.

Which pneumonia shot does the CDC recommend at 50 and older?

The CDC now recommends a pneumococcal shot for everyone 50 and older, down from 65 a couple of years ago. Before the change, a shot at that age depended on having a condition that raised the risk, and most people who qualified that way never got one. Younger adults still qualify if they have something like diabetes, chronic heart, lung or liver disease, a cochlear implant or an immune problem, or if they smoke.

If you’ve never had a pneumococcal shot

The CDC lists three options without ranking them: Prevnar 20, Capvaxive, or Vaxneuvance, a 15-strain shot also made by Merck. One dose of Prevnar 20 or Capvaxive completes the series, with nothing more needed afterward. Vaxneuvance is the one that comes as a pair: it’s followed a year or more later by Pneumovax 23, an older type of pneumonia shot. That means one visit with Prevnar 20 or Capvaxive, or two visits at least a year apart with Vaxneuvance.

If you’ve had an older pneumonia shot

Two older shots still show up on a lot of vaccine records: Pfizer’s earlier Prevnar 13 and Pneumovax 23. Plenty of people got one of these older shots years ago and only half remember which. The next step depends on that history:

  • Prevnar 13 only: Prevnar 20 or Capvaxive, at least 1 year later.
  • Pneumovax 23 only: any of the three options above, at least 1 year later, with no second Pneumovax 23 if Vaxneuvance is the one you get.
  • Both: Prevnar 20 or Capvaxive, at least 5 years after the last of them.

There’s one wrinkle if you’ve had both older shots and the Pneumovax 23 came at 65 or later. For you, one more shot is optional, and it’s worth talking over with a doctor or pharmacist. Before the visit, dig out your vaccine card or ask the pharmacy or your doctor’s office to look up your record. How long you wait depends on which shots you had and when, so having the record saves you the guesswork.

More Helpful Reads You Might Like:

Frequently Asked Questions

Is there a Prevnar 21?

Not under that name. The 21-strain pneumococcal vaccine is sold as Capvaxive and made by Merck, so that’s the name you’ll see on a pharmacy screen or your vaccine record. Prevnar 20 is Pfizer’s 20-strain shot, a different vaccine that shares only 10 strains with Capvaxive.

Is Capvaxive better than Prevnar 20?

Nobody can say yet. Its strains match more of the serious infections adults get today, but it was approved based on antibody tests rather than on how many people stayed healthy. The CDC lists it alongside Prevnar 20 without ranking either one.

Do I need Pneumovax 23 after Prevnar 20 or Capvaxive?

No. Under current CDC guidance, a single dose of either one is all you need. Pneumovax 23 is paired only with Vaxneuvance, Merck’s 15-strain shot, and comes at least a year after it.

Can I get Capvaxive if I already had Prevnar 20?

Not at this point. The CDC considers one Prevnar 20 shot enough on its own and doesn’t recommend adding another pneumococcal shot on top of it. Whether protection fades enough to need a booster someday isn’t known yet.

What are the side effects of Capvaxive?

The usual ones are pain where the shot went in, tiredness and headache, and they tend to pass in a day or two. In the label’s data, about 4 in 10 adults 50 and older reported arm pain, and younger adults reported it more often.

Medical Disclaimer: This content is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment. Always consult your physician or a qualified healthcare provider with any questions about a medical condition.

Sources & Further Reading

How we sourced this article: we rely on peer-reviewed studies, clinical guidelines and public-health agencies (CDC, NIH, AHA, WHO), check every link before publishing, and update articles when the evidence changes. Read our editorial approach.

Vital Care Guide Editorial Team

Physician-led editorial team. Every article is written from current guidelines and peer-reviewed sources, cited at the end, and revised when the evidence changes. This content is for information only and is not a substitute for medical advice. How we work

Medical editor: Jhonatas Ribeiro, MD, Internal Medicine Specialist

Keep reading